FDA warning letters provide insight into the most common inspection findings so clinical investigators can prevent them.
Topics: BIMO FDA Inspection
You want to keep your trial on track, but physical distancing and travel restrictions have made it difficult. Fortunately, IMARC has experience providing remote services.
FDA warning letters provide insight into the most common inspection findings so clinical investigators can prevent them.
Topics: BIMO FDA Inspection
Does the thought of a BIMO inspection make you break into a cold sweat?
It’s worth remembering that although BIMO FDA inspections might feel like a pop quiz, this is one test the FDA wants you to pass. That’s why the FDA provides detailed guidance on what its investigators will review, similar to a study guide.
To prepare your site to pass, take time to review our BIMO FDA inspection cheat sheet.
Topics: BIMO FDA Inspection
The Bioresearch Monitoring (BIMO) FDA inspections are an important part of the preapproval process, designed to assure the quality and integrity of study data and adequate protection of the rights and welfare of human subjects. While a BIMO inspection may feel like a pop quiz, the FDA’s goal isn’t for sponsors to fail, but to equip them to pass. By taking a proactive approach to training and preparing, study sponsors can help their site coordinators greet inspectors with confidence. Here’s a quick refresher on BIMO FDA inspections and three steps sponsors can take to prepare.
Topics: BIMO FDA Inspection